In 2013, Nekhlyudov served a member of the National Academy of Medicine (NAM, formerly the Institute of Medicine) panel on cancer care quality. She is also serving on the Executive Committee of the Cancer and Primary Care International Research Network, the Advisory Board of the Massachusetts Cancer Registry, and the Survivorship Work Group at the Massachusetts Comprehensive Cancer Prevention and Control Network. Over the past decade, she has also served as co-director of the Harvard Medical School/Dana-Farber Cancer Institute CME conference on cancer survivorship. In 2015, Nekhlyudov left the Harvard Vanguard Medical Associates to join the Brigham and Women's Hospital's primary care practice. At the beginning of 2018, Nekhlyudov was elected as the inaugural scholar to participate in the National Cancer Institute (NCI)/AcademyHealth Healthcare Delivery Research Visiting Scholars Program. Through the program, she worked on "improving the care of cancer survivors and the interplay between primary and oncologic care." She is also an associate editor for the peer-reviewed medical journal covering oncology nursing with respect to cancer survivors called Journal of Cancer Survivorship and
